Dr. Tippi Mackenzie is an Associate Professor of Surgery at the University of California, San Francisco. Her lab’s recent research looks at a hereditary disease that affects the blood cells known as Alpha Thalassemia Major. This disorder is known to be often incompatible with life and consequently must be identified in utero.
Pediatric Surgeon Tippi MacKenzie, MD was awarded $12.1 million by the California Institute for Regenerative Medicine (CIRM) to treat babies in the womb suffering from alpha thalassemia major, a blood disorder that is only detected in the last few months of pregnancy and is almost uniformly fatal.
Tippi and Mary discuss how and why the CMFPM is bringing together expert scientists and clinical researchers to develop precision therapies that will improve the health of pregnant women and babies all over the world.